Related Experiment Videos

Insights

Pacemaker implantation site infections occurred in 1.06% of 1,789 patients. Staphylococcus epidermidis infections responded to conservative treatment, while other organisms required new pacemaker reimplantation.

Area of Science:

  • Cardiology
  • Infectious Diseases
  • Surgical Site Infections

Background:

  • Pacemaker implantation is a common procedure.
  • Surgical site infections (SSIs) are a potential complication.
  • Understanding infection rates and causative organisms is crucial for patient outcomes.

Purpose of the Study:

  • To determine the incidence of pacemaker implantation site infections.
  • To identify the microorganisms responsible for these infections.
  • To evaluate treatment outcomes based on the causative organism.

Main Methods:

  • Retrospective review of 1,789 pacemaker implantations performed between January 1963 and September 1978.
  • Analysis of infection development, incidence rates, and microbiological cultures.
  • Correlation of treatment strategies with patient outcomes.

Main Results:

  • A total of 19 infections (1.06%) were identified among 1,789 pacemaker implantations.
  • Staphylococcus epidermidis was the most frequently isolated organism.
  • Patients infected with S. epidermidis achieved successful outcomes with conservative management.
  • Infections caused by other microorganisms necessitated device reimplantation in a new surgical site.

Conclusions:

  • Pacemaker implantation site infections are infrequent but serious complications.
  • The predominant organism, Staphylococcus epidermidis, can often be managed non-surgically.
  • Alternative pathogens require more aggressive treatment, including reimplantation, to resolve infection and ensure device function.

Related Concept Videos